Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Biotechnology

Education

Verve Therapeutics

Sekar Kathiresan

Bharathi Gandi

Michael Baladiang

Leandro Alcantara

Andrea Bartucca

Abigail Eisner

William Toth

Hongyun Zhao

Samantha Morales

Payal Pranami

Nidhi Sharon Das

Michael Zukowski

Mackenzie Schoenthaler

Alexa Van Amerongen

Ann Dougherty

Erin Garrity

Yang Jiao

Michael Amaonye

Srinidhi Sridhar

Estela Shabani

Ryan Santos

Jack Ganey

Jamie Denizio

Vidya Subramanian

Jeffrey Li

Francis Wong

Alexandra Chadwick

Khushboo Undavia

Vian Peshdary

Anthony Lohmeier

Ananda Mishra

Liam Cornell

David Bassen

Mierzhati Mushajiang

Victor Farutin

Holly Beatrice

Carina Nyberg Washington

Danielle Montt

Zoe Schumacher

Kristina Dibble

Erin Hood

Cody Suliveras-Jardine

Shanelle Samuels

Dan Balian

Marina Varlamova

Alex DiMario

Kevin Layton

Praveen Prasanna

Amanda Demeritt

Casey Hannigan

Jessie Colgan

Cris Wein

Allison Krunnfusz

Alfons Koziol

Krista Petty

Jill Wilson

Erin Brady

Mark Geng

Jonathan Wu

James Lynch

Steve Briscoe

Stephen Johnson

Pratik Randeria

Joe Biedenkapp

Troy Lister

Emily Cronin

Jeffrey Meltzer

Victoria Bartlett

Yasser El-Gamal

Seka Lazare

Allison Dorval

Andrew Sheely

Barry Ticho

Andrew Bellinger

J. Keith Joung

Caitlin Moreno

Andrew Ashe

Kallanthottathil G. Rajeev

Leslie Stolz

Research and Development

Leadership Team

Manufacturing and Supply Chain

Quality Control and Assurance

Finance and Accounting

Regulatory Affairs and Compliance

Clinical Operations and Management

Teams at Verve Therapeutics